Suppr超能文献

巴基斯坦查尔萨达地区β地中海贫血症分子异质性的调查。

Investigation of molecular heterogeneity of β-thalassemia disorder in District Charsadda of Pakistan.

作者信息

Shakeel Muhammad, Arif Muhammad, Rehman Shoaib Ur, Yaseen Tabassum

机构信息

Dr. Muhammad Shakeel, PhD (UK). Department of Biotechnology, Bacha Khan University Charsadda, Khyber Pakhtunkhwa, Pakistan.

Mr. Muhammad Arif, M.Phil. Department of Biotechnology, Bacha Khan University Charsadda, Khyber Pakhtunkhwa, Pakistan.

出版信息

Pak J Med Sci. 2016 Mar-Apr;32(2):491-4. doi: 10.12669/pjms.322.9415.

Abstract

OBJECTIVE

Thalassemia is blood related disease which arises from the reduced level of hemoglobin in red blood cells (RBC), a protein responsible for carrying oxygen inside the body. Considering its widespread occurrence in developing countries like Pakistan, this study aims to investigate the common molecular anomalies of the beta thalassemia disease in district Charsadda, Khyber Pakhtunkhwa.

METHODS

This work was done at Abdul Wali Khan University (AWKU) Mardan, Khyber Pakhtunkhwa, Pakistan. The work was performed on the blood samples collected from the patients and their families with beta thalassemia major (n = 13 families) belonged to District Charsadda. The collected blood samples were analyzed for presence of six known mutations with the help of polymerase cha in reaction technique i.e. amplification of refractory mutation system.

RESULTS

Our Study reports six known mutations (IVS-1-5, FSC 8/9, CD 41/42, IVS-1-1, CD 15 and FSC-5) accounting for about 90% of total beta thalassemia genes in this country. Among the reported mutations, IVS 1-5 was the most prevalent beta thalassemia gene in patients belonging to District Charsadda.

CONCLUSION

The results and findings of the current study may help in accessing the frequency of these common mutations and in initiating pre-natal diagnosis programme in Pakistan.

摘要

目的

地中海贫血是一种血液相关疾病,由红细胞(RBC)中血红蛋白水平降低引起,血红蛋白是一种负责在体内携带氧气的蛋白质。鉴于其在巴基斯坦等发展中国家广泛存在,本研究旨在调查开伯尔-普赫图赫瓦省查尔萨达地区β地中海贫血疾病常见的分子异常情况。

方法

这项工作在巴基斯坦开伯尔-普赫图赫瓦省马尔丹的阿卜杜勒·瓦利·汗大学(AWKU)开展。对从查尔萨达地区患有重型β地中海贫血的患者及其家属(n = 13个家庭)采集的血样进行研究。借助聚合酶链反应技术,即难治性突变系统扩增技术,对采集的血样进行六种已知突变的检测。

结果

我们的研究报告了六种已知突变(IVS-1-5、FSC 8/9、CD 41/42、IVS-1-1、CD 15和FSC-5),这些突变约占该国β地中海贫血基因总数的90%。在报告的突变中,IVS 1-5是查尔萨达地区患者中最常见的β地中海贫血基因。

结论

本研究的结果和发现可能有助于了解这些常见突变的频率,并在巴基斯坦启动产前诊断项目。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84cf/4859051/ab0f8f91a3aa/PJMS-32-491-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验